Davinder Singh Brar
Gurugram
Investments
Investment
time of Investment
About Davinder Singh Brar
D S Brar is a life sciences industry veteran, with a career spanning over four decades. Prior to joining Aragen (formerly known as GVK BIO) as Promoter-Chairman, Mr Brar led Ranbaxy Laboratories Ltd. as CEO and Managing Director. In 2004, he embarked on an entrepreneurial journey to establish Aragen as a leading biopharmaceutical R&D and manufacturing partner to the global life sciences industry. Mr Brar also promoted Inogent Laboratories, an early development/scale-up company (which has since merged with Aragen), Excelra Knowledge Solutions, a data structuring and analytics company, and Davix Management Services, a pharmaceutical-focused con (Show more)
Davinder Singh Brar Prominent Investment Areas
Business Support Services Clean-Tech Consumer Services +4 more investments
Key Focus Areas of invested Startups by Davinder Singh Brar
Data Services Data Sharing Electric Mobility Technology +9 more focus areasDavinder Singh Brar Recent Experience
Chairman
GVK BIosciences Private Limited, India
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly reach out to sales@ynos.in
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
